© UPI
First real-world study shows Pfizer-BioNTech COVID-19 vaccine 94% effective
The coronavirus vaccine developed by Pfizer and BioNTech has performed as well in real-world conditions as it did in clinical trials, according to the first study of its kind of the COVID-19 era.